Ellis Investment Partners, LLC Exact Sciences Corp Transaction History

Ellis Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $639 - $987	20 Added 5.48%	385 $12,000
Q2 2022 Aug 01, 2022	BUY	$35.61 - $76.23 $2,314 - $4,954	65 Added 21.67%	365 $14,000
Q4 2021 Feb 01, 2022	BUY	$72.5 - $100.68 $8,482 - $11,779	117 Added 63.93%	300 $23,000
Q3 2021 Oct 21, 2021	BUY	$90.24 - $124.05 $902 - $1,240	10 Added 5.78%	183 $17,000
Q2 2021 Jul 26, 2021	BUY	$93.66 - $139.27 $8,991 - $13,369	96 Added 124.68%	173 $21,000
Q1 2021 May 03, 2021	BUY	$116.57 - $155.01 $8,975 - $11,935	77 New	77 $10,000

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.81B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.